Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px
Organisation › Details

Vaximm (Group)

VAXIMM is a privately held, Swiss and German biotech company that is developing oral T-cell vaccines as immunotherapies for patients suffering from cancer. VAXXIM's product platform is based on a live attenuated, safe, orally available bacterial vaccine strain, which is modified to stimulate patients' cytotoxic T-cells (so-called killer cells) to target specific structures of their tumor. VAXIMM's lead product candidate, oral VXM01, activates killer cells targeting tumor-specific vasculature and certain immune-suppressive cells, increasing immune cell infiltration in solid tumors. In addition to VXM01, VAXIMM has a pipeline of complementary development candidates targeting different tumor structures. VAXIMM's investors include BB Biotech Ventures, Merck Serono Ventures, Sunstone Capital and BioMed Partners. VAXIMM AG is headquartered in Basel, Switzerland. Its fully owned subsidiary, VAXIMM GmbH, located in Mannheim, Germany, is responsible for the Company' clinical operations. *

 

Period Start 2011-01-15 existent
  Predecessor Merck (DE) (Group)
Products Industry therapeutic vaccine
  Industry 2 VXM01 cancer vaccince
     
Region Region Basel BS
  Country Switzerland
  Street 3 Elisabethenstr.
  City 4051 Basel BS
    Address record changed: 2011-05-14
     
Basic data Employees n. a.
     
    * Document for »About Section«: Vaximm AG. (5/4/16). "Press Release: Vaximm Initiates Phase 2a Study in Advanced Colorectal Cancer with Oral T-cell Vaccine VXM01". Basel & Mannheim.
     
   
Record changed: 2017-04-01

Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px

More documents for Vaximm (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture BCNP Consultants European Chemistry Partnering 2018 Ffm Germany 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px